Valuation : Terumo Corporation

Market Cap 3,640B 23.39B 20.13B 18.89B 17.28B 32.26B 2,211B 32.51B 223B 87.02B 1,130B 87.85B 85.93B P/E 2027 *
18.4x
P/E 2028 * 19x
Enterprise Value 3,686B 23.69B 20.38B 19.13B 17.5B 32.66B 2,239B 32.92B 226B 88.12B 1,144B 88.96B 87.02B EV / Sales 2027 *
2.93x
EV / Sales 2028 * 2.7x
Free-Float
97.07%
Yield 2027 *
1.5%
Yield 2028 * 1.65%
1 day-0.06%
1 week-4.06%
Current month-1.93%
1 month+6.17%
3 months+9.74%
6 months+21.07%
Current year+8.70%
1 week 2,446.5
Extreme 2446.5
2,579
1 month 2,280
Extreme 2280
2,689
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,696.5
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.06%-4.06%-7.43%+11.58% 22.96B
-1.64%-2.66%-17.82%+7.68% 191B
+0.41%+2.63%+0.09%+15.13% 118B
+0.25%+4.83%+14.10%+94.80% 64.19B
+0.16%-2.02%+26.41%+50.66% 51.49B
-0.20%-0.66%-1.43%-31.51% 51.08B
-0.19%+0.35%+13.53%-10.69% 33.85B
+0.01%+4.69% - - 31.85B
-0.52%-1.39%+37.09%-15.45% 24.11B
-0.98%-2.20%-6.03%+1.88% 22.46B
Average -0.26%-1.09%+6.50%+13.79% 61.11B
Weighted average by Cap. -0.46%-1.98%-0.27%+17.11%

Financials

2027 *2028 *
Net sales 1,259B 8.09B 6.96B 6.53B 5.98B 11.15B 765B 11.24B 77.27B 30.09B 391B 30.38B 29.72B 1,339B 8.61B 7.4B 6.95B 6.36B 11.86B 813B 11.96B 82.19B 32.01B 416B 32.31B 31.61B
Net income 195B 1.25B 1.08B 1.01B 926M 1.73B 118B 1.74B 11.97B 4.66B 60.52B 4.7B 4.6B 192B 1.23B 1.06B 996M 911M 1.7B 117B 1.71B 11.78B 4.59B 59.57B 4.63B 4.53B
Net Debt 45.99B 296M 254M 239M 218M 408M 27.94B 411M 2.82B 1.1B 14.28B 1.11B 1.09B -26.39B -170M -146M -137M -125M -234M -16.04B -236M -1.62B -631M -8.2B -637M -623M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
03/09/26 ¥2,467.50 -0.06% 3,345,100
02/09/26 ¥2,469.00 -2.97% 4,819,400
01/09/26 ¥2,544.50 +1.13% 2,819,800
31/08/26 ¥2,516.00 -0.91% 5,581,400
28/08/26 ¥2,539.00 -0.82% 3,795,800
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,467.50JPY
Average target price
3,140.77JPY
Spread / Average Target
+27.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock